Healthcare
India pharma industry to hit over $38b by 2022
India pharma industry to hit over $38b by 2022
The government is urged to create a research ecosystem that will support the sector's growth.
Smart visa driven medical tourism boom threatens to overwhelm Thai public hospitals
About 1.4 million international patients received medical treatment in 2012.
Can the Philippines implement national membership programmes in its UHC push?
The private sector can be tapped for its extensive expertise in delivering high-quality care.
GIC and investment firm KKR invest $940m in Philippine hospital group
The consortium will subscribe to $136.67m worth of 41.3 million new common shares.
Top five healthcare stocks in Singapore averaged total returns of 29.5% YTD
ISEC leads the pack at 48.6%.
Singapore, Philippines spearhead medtech across SEA
The Lion City’s Diagnostics Development hub has delivered 400 technologies and four products since 2014.
India e-health record market to grow at 5% CAGR to 2025
The implementation of UHC will fuel the shift to digital.
HC Surgical Specialist profits up 38% to $880,000 in Q1
New acquisitions from the previous financial year brought growth.
Japanese pharma sales take hit from 'opaque' pricing system
It will grow at a CAGR of 2.3% to $124b in 2023.
Rentschler strengthens Japanese ties with Summit Pharmaceuticals
The East Asian country is the world’s third largest pharmaceuticals market.
Rentschler strengthens Japanese ties with Summit Pharmaceuticals
The East Asian country is the world’s third largest pharmaceuticals market.
Rentschler strengthens Japanese ties with Summit Pharmaceuticals
The East Asian country is the world’s third largest pharmaceuticals market.
Top Chinese drug distributors grapple with tepid margins
Blame the two-invoice system.
Chinese pharmas face price pressures from Indian entrants under GPO
The entrance of Indian players may cut prices further by 30%.
10 in 11 APAC healthcare groups saw negative shareholder returns in 2016-2018: Bain
Rising costs, evolving regulations and reimbursement pressure eroded profits.
APAC's employer medical benefit costs may rise 8.7% in 2020
This growth will be led by Malaysia and Thailand.
Singapore lost $1.04b to migraines in 2018
Patients who experienced it for four to 14 days per month lost an average of $14,860.
Resource Center
Read Here
Advertise
Sign Up
Awards
Apr
10
Event News
The awards programmes honour outstanding leaders and companies in the healthcare industry across Asia.
